Cervical Adenosquamous Cell Carcinoma Completed Phase 3 Trials for Bevacizumab (DB00112)

Also known as: Cervical Adenosquamous Carcinoma / Adenosquamous carcinoma of the cervix / Adenosquamous carcinoma of cervix (disorder)

IndicationStatusPhase
DBCOND0034091 (Cervical Adenosquamous Cell Carcinoma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00803062Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical CancerTreatment